The largest database of trusted experimental protocols

3 protocols using dimethyldioctadecylammonium

1

Preparation and Characterization of Fluorescent Lipid Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dimethyldioctadecylammonium was obtained from Avanti Polar Lipids (Alabaster, AL, United States). TDB was purchased from Niels Clauson-Kaas A/S (Farum, Denmark). Xenolight 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide (DiR) near infra-red fluorescent dye was purchased from Perkin Elmer (Waltham, MA, United States). H56 protein was produced recombinantly in E. coli as previously described (15 (link)), reconstituted in 20 mM glycine buffer (pH 8.8), checked for purity, and validated for residual DNA, endotoxins and bioburden following internal good manufacturing practice standards at Statens Serum Institut as described previously (16 (link)). Alexa Fluor® 647-labeling of H56 was performed commercially (Thermo Fischer Scientific, Eugene, OR, United States). 2,5-dihydroxybenzoic (DHB), 1,5-diaminonaphthalene (DAN), trifluoroacetic acid (TFA), and Meyer’s hematoxylin solution and eosin (H&E) solution were purchased from Sigma-Aldrich (St. Louis, MO, United States). Methanol was obtained from Th. Geyer (Renningen, Germany). Water was prepared by using a Millipore Direct-Q3 UV system (Billerica, MA, United States). All other chemicals and reagents were of analytical grade and were acquired from commercial suppliers.
+ Open protocol
+ Expand
2

Liposome Preparation for Angiogenin Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liposomes were generated by lipid film hydration as described (Kallert et al., 2015 (link)). Briefly, dimethyldioctadecylammonium (DDA; 0.3 mg/ml; Avanti Polar Lipids), D-(+)-trehalose 6,6′-dibehenate (TDB; 0.25 mg/ml; Avanti Polar Lipids, Sigma Aldrich) and L-α-phosphatidylcholine (PC; 0.9 mg/ml; Avanti Polar Lipids) were mixed in chloroform (VWR): methanol (Sigma-Aldrich; 9:1, v/v). The organic solvents were evaporated under nitrogen flow. Liposomes were formed by hydrating the lipidfilm in 500 μl 10 mM Tris-buffer (pH 7.4; Sigma-Aldrich) for 25 min at 57°C within between vortexing, as previously described (Kennerknecht et al., 2020 (link)). Angie1 or Angiogenin were added in a 1:1 mixture to the liposomes at a final concentration of 2.7 mM. The size of liposomes was determined by Nanoparticle Tracking Analysis (NTA) using a ZetaView TWIN (Particle Metrix, Inning, Germany). Samples were diluted in TRIS-buffer and videos of the light-refracting particles were recorded with the following settings: 25°C fixed temperature, 11 positions, 1 cycle, sensitivity 85, shutter 100, 15 fps, 2 s videos/position, and six measurements. The number and size distribution were evaluated by ZetaView Analyze (Version 08.05.05 SP2), as previously described (Conzelmann et al., 2020 (link)).
+ Open protocol
+ Expand
3

Multifunctional Nanocarrier for Targeted Drug Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetraethyl orthosilicate (TEOS), triethanolamine (TEA), cetyltrimethylammonium chloride (CTAC, 25 wt%), 3-aminopropyltriethoxysilane (APTES), fluorescein isothiocyanate (FITC), N-hydroxysuccinimide (NHS), 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (NHS), α-tocopherol, cysteamine, and doxorubicin hydrochloride were purchased from Sigma-Aldrich (USA). 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), cholesterol, 1.2-distearoyl-sn-glycerol-3-phosphoethanolamine-N-[amino (polyethylene glycol)-2000] (ammonium salt, DSPE-PEG2000), dimethyldioctadecylammonium (bromide salt, DDAB), and 1.2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide (polyethylene glycol)-2000] (ammonium salt, DSPE-PEG2000-MAL) were purchased from Avanti Polar Lipids (Birmingham, AL, USA). 1,1ʹ-Dioctadecyl-3,3,3ʹ,3ʹ-tetramethylindocarbocyanineperch-lorate (DiI) was purchased from Beyotime Biotechnology (Jiangsu, China). TATp (YGRKKRRQRRR) and (FITC)-C6-TAT (TAT: YGRKKRRQRRR) were synthesized by Shanghai Sangon Biotech Co. Ltd. (Shanghai, China). SH- and FITC-modified TLS11a aptamer 3ʹ-SH-AAAAAAACAGCATCCCCATGTGAACAATCGCATTGTGATTGTTACGGTTTCCGCCTCATGGACGTGCTG-5ʹwere synthesized by Shanghai Sangon Biotech Co., Ltd. (Shanghai, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!